4
Changes in Ownership
Parabilis Medicines, Inc. Filed Acc 0001231919-26-000779
Director bought 244,593 shares at an average $28.29 ($6,919,551)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. Director | 2026-07-20 | Purchase | +98,433 | $27.13 | $2,670,487 | 26,383,526 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2026-07-20 | Purchase | +32,987 | $27.72 | $914,400 | 26,416,513 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2026-07-21 | Purchase | +21,696 | $27.96 | $606,620 | 26,438,209 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2026-07-21 | Purchase | +6,504 | $29.17 | $189,722 | 26,444,713 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2026-07-21 | Purchase | +37,723 | $30.00 | $1,131,690 | 26,482,436 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2026-07-22 | Purchase | +47,250 | $29.77 | $1,406,633 | 26,529,686 | I |
| Open-market purchases · 244,593 sh · avg $28.29 · $6,919,551 | |||||||
Loading xslF345X06/form4-07222026_080742.xml…